Taisho Pharmaceutical Ind (SQBI_p)

Jakarta
440,000
0(0.00%)
  • Volume:
    0
  • Bid/Ask:
    420,000/460,000
  • Day's Range:
    440,000 - 440,000

SQBI_p Overview

Prev. Close
440,000
Day's Range
440,000-440,000
Revenue
-
Open
440,000
52 wk Range
0-0
EPS
4,234.81
Volume
0
Market Cap
4.08T
Dividend (Yield)
17,000.00
(N/A)
Average Vol. (3m)
200
P/E Ratio
-
Beta
-
1-Year Change
0%
Shares Outstanding
9,268,000
Next Earnings Date
-
What is your sentiment on Taisho Pharma Ind?
or
Vote to see community's results!

Taisho Pharmaceutical Ind Company Profile

Taisho Pharmaceutical Ind Company Profile

Employees
154
Market
Indonesia

PT Taisho Pharmaceutical Indonesia Tbk engages in the development, registration, processing, production, and sale of chemical, pharmaceutical, and health care products. The company offers over-the-counter products, including Counterpain, Tempra, multi-vitamin, and skin care products, as well as ethical products in domestic and export markets. Its products are offered in the form of tablets, capsules, ointments, powders, patches, and other forms. The company was formerly known as PT Squibb Indonesia and changed its name to PT Taisho Pharmaceutical Indonesia Tbk in November 2009. The company was founded in 1970 and is headquartered in Jakarta, Indonesia. PT Taisho Pharmaceutical Indonesia Tbk is a subsidiary of Taisho Pharmaceutical Co., Ltd.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary